Last reviewed · How we verify
NCT07423507
Comparative Study Between Internal Fixtion And Primary Subtalar Arthrodesis In Comminuted Intra-Articular Calcaneal Fracture
NA trial testing Primary Subtalar Arthrodesis in Calcaneus Fractures in 40 participants. Not yet recruiting.
2 January 2028
Quick facts
| Lead sponsor | Ahmed Gamal Ibrahim Saleh |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 March 2026 |
| Primary completion | 2 January 2028 |
| Estimated completion | 2 January 2028 |
Drugs / interventions tested
- Primary Subtalar Arthrodesis
- Open reduction and internal fixation
Conditions studied
- Calcaneus Fractures — all drugs for Calcaneus Fractures →
Sponsor
Ahmed Gamal Ibrahim Saleh
Who can join
Adults 18 to 65, any sex, with Calcaneus Fractures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to compare clinical outcome of Sanders type III or IV intra-articular calcaneal fracture treated with open reduction and internal fixation (ORIF) versus ORIF and primary subtalar arthrodesis (PSTA).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07423507
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Calcaneus Fractures
Currently open trials in the same condition.
- NCT07111897 — Plate Fixation Versus Percutaneous Cannulated Screw Insertion in Sanders Type II and Type III Calcaneal Fractures · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07423507 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ahmed Gamal Ibrahim Saleh
- Last refreshed: 20 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07423507.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing